Sources: Hsieh MJ, Liu HT, Wang CN, et al
We employ a GRX-based selective reduction protocol, where glutathionylated cysteines are specifically reduced and tagged for enrichment
In some embodiments, the otic formulation or composition comprises between about 0.01% to about 50% by weight of the therapeutic agent, or pharmaceutically acceptable prodrug or salt thereof
The antioxidant effects of NAC are further reinforced by additional mechanisms, which include Nrf2-ARE pathway activation [19,20], direct scavenging of ROS and reactive nitrogen species, detoxifying lipid-derived electrophilic compounds, and boosting the activity of glutathione peroxidase (GPx) and glutathione-S-transferase (GST) [4,21]
What it does not include is a deep bench of large human randomized controlled trials establishing exact onset times or effect sizes in people